Citeline's Director of Regulatory Intelligence will provide jurisdiction-specific insights and practical best practices to build proactive, multi-registry compliance strategies and stay ahead of an evolving transparency landscape.
Citeline is proud to participate in PHUSE Data Transparency Autumn Event, taking place virtually on 15–17 September 2026.
This event will explore the evolving landscape of clinical data transparency, including approaches to data sharing, anonymisation, governance, and enabling responsible access to clinical data.
Learn more by visiting the event website.
Learn more about our session below.
Africa and Latin America represent more than 25% of the world’s population, yet account for fewer than 8% of global clinical trials. Despite this small trial footprint, the transparency landscape remains highly fragmented.
Across 74 countries, only 25 carry mandatory or voluntary registration requirements, yet the variation between them is significant. Sponsors face a patchwork of national versus internationally recognised registries, inconsistent results disclosure timelines, and enforcement mechanisms ranging from financial penalties to criminal sanctions.
This session cuts through the complexity using a practical ‘what, when, where and why’ framework: what protocols and results must be disclosed? When are registration obligations triggered? Where must registration occur? And why does compliance matter, particularly where enforcement carries real operational and legal risk?
Drawing on global disclosure data and regulatory developments through 2026, attendees will gain jurisdiction-specific insights and practical best practices to build proactive, multi-registry compliance strategies and stay ahead of an evolving transparency landscape.
Ben Evans
Director, Regulatory Intelligence, Citeline
Ben Evans leads the development and evolution of TrialScope Intelligence, a global clinical trial regulatory intelligence platform that delivers high-quality, actionable content to help clients navigate complex disclosure regulations. His role combines research, strategy, and cross-functional collaboration, working closely with regulatory experts, product, tech, and commercial teams to ensure alignment with client needs and company goals.